Hologic Inc. (NSDQ:HOLX) wants a federal judge in Ohio to reconsider his ruling allowing Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery Inc. to pursue patent infringement claims in its lawsuit over breast biopsy technology.
Ethicon sued Hologic in 2007, accusing the Bedford, Mass.-based women’s health products maker of violating a quartet of patents related to Ethicon’s Mammotome breast biopsy system with Hologic’s ATEC system, and of violating false advertising laws.